Timothy S. Zheng is at Biogen Inc.,
14 Cambridge Center, Cambridge, Massachusetts
02142, USA. timothy_zheng@biogen.com
Members of the Bcl-2 family are critical regulators of apoptosis
and have become attractive targets for the development of anti-cancer drugs.
The latest discovery of small-molecule inhibitors of Bcl-2 proteins may provide
the sought-after leads for the development of new anti-cancer therapy
